DT&CRO CO., LTD.DT&CRO CO., LTD.DT&CRO CO., LTD.

DT&CRO CO., LTD.

No trades
See on Supercharts

383930 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

DT&CRO Co. Ltd. engages in the research and development of medicine and pharmaceuticals. It provides a full-service series of consignment studies ranging from non-clinical GLP toxicity, PK, and efficacy tests to analysis, livelihood, clinical trials, and licensing consultations required for licensing medicines, chemicals, health-function foods, cosmetics, and medical devices. The company was founded on April 3, 2017 and is headquartered in Yongin-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
383930 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company